Telmisartan Methyl Ester is a benzimidazole-based angiotensin II receptor antagonist derivative featuring a methyl ester substitution at the terminal carboxylic acid moiety of the parent Telmisartan structure. The compound retains the core 4-chlorophenylpiperidin-1-yl and tetrazole functionalities critical for pharmacological activity but exhibits altered hydrolytic stability due to esterification. This impurity arises during synthetic pathways involving esterification reactions or non-enzymatic degradation under acidic conditions. Structurally, it serves as a key HPLC reference standard for quantifying process-related impurities in Telmisartan active pharmaceutical ingredient batches.
On RequestCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)OC)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
InChI=1S/C34H32N4O2/c1-5-10-31-36-32-22(2)19-25(33-35-28-13-8-9-14-29(28)37(33)3)20-30(32)38(31)21-23-15-17-24(18-16-23)26-11-6-7-12-27(26)34(39)40-4/h6-9,11-20H,5,10,21H2,1-4H3
HJCCZIABCSDUPE-UHFFFAOYSA-N